<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>GBI - China pharma, biotech, and health news</title><link>http://www.gbipharma.com</link><description></description><language>en-us</language><copyright>Copyright 2007 Generalbiologic</copyright><lastBuildDate>Fri, 30 Jul 2010 08:56:20  +0800</lastBuildDate><image><title>GBI - China pharma, biotech, and health news</title><url>http://www.gbipharma.com/google-pic.jpg</url><link>http://www.gbipharma.com</link></image><item><title>On-line central drug procurement set for 30day roll-out in Heilongjiang</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>Heilongjiang Province has officially launched internet-based centraliz......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 29 Jul 2010 17:41:57  +0800</pubDate></item><item><title>Kangmei Pharmaceutical plans Sichuan TCM investments of RMB 600 million </title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>Kangmei Pharmaceutical (SHA:600518) has announced plans acquire Langzh......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 29 Jul 2010 17:01:11  +0800</pubDate></item><item><title>Leo Pharmaceutical recalls IV antibiotic product in China</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The State Food and Drug Administration (SFDA) received a report from I......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 29 Jul 2010 16:14:59  +0800</pubDate></item><item><title>HCV is China¡¯s main focus on World Hepatitis Day</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>On the occasion of the first World Hepatitis Day July 28, the Ministry......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 29 Jul 2010 14:55:36  +0800</pubDate></item><item><title>Major foreign CT/MRI OEMs see large China potential, despite obstacles</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>Leading global computed tomography (CT) scanner manufacturers, General......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 29 Jul 2010 14:07:23  +0800</pubDate></item><item><title>Qinghai health department in gear to help earthquake reconstruction</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The Qinghai provincial health department recently formulated and issue......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 29 Jul 2010 13:33:31  +0800</pubDate></item><item><title>Novartis signs artimether API purchase agreement with Kunming Pharma</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>Kunming Pharmaceutical Corporation (KPC) (SHA: 600422) a subsidiary of......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 28 Jul 2010 16:57:38  +0800</pubDate></item><item><title>Doctors make mouse calls: Beijing hospital launches pilots access system</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The 3rd Hospital of Peking University has officially launched an onlin......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 28 Jul 2010 15:29:30  +0800</pubDate></item><item><title>SFDA continues to target illegal drug/device advertising</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The State Food and Drug Administration (SFDA) will reportedly crack do......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 28 Jul 2010 13:46:35  +0800</pubDate></item><item><title>Close fitting genes- Affymetrix to launch China specific SNP microarray</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>Affymetrix, Inc. (NASDAQ: AFFX) recently announced plans to develop an......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 28 Jul 2010 13:37:30  +0800</pubDate></item><item><title>MSD-Sinopharm marketing partnership seems likely</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>Merck  and  Co. recently announced that it has signed a statement of mutua......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 28 Jul 2010 12:29:53  +0800</pubDate></item><item><title>RDPAC raises strong objection to NRDC drug pricing draft measures</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>Over twenty foreign pharmaceutical companies belonging to the R and D-base......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Tue, 27 Jul 2010 17:10:07  +0800</pubDate></item><item><title>Beijing municipal health bureau releases rosy reform rollout report</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The Beijing municipal health bureau has been promoting projects detail......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Tue, 27 Jul 2010 16:01:07  +0800</pubDate></item><item><title>Pain, pain, go away- high tech anesthesia center set up in Guangdong</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The Southern Anesthesia Monitoring Technology Training Center (GBI tra......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Tue, 27 Jul 2010 14:48:11  +0800</pubDate></item><item><title>Nanjing Tongrentang plans RMB 600 infrastructure investment</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>Nanjing Tongrentang (TRT) Pharmaceutical and Oukai Pharmaceutical rece......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Tue, 27 Jul 2010 14:44:54  +0800</pubDate></item><item><title>Major counterfeit drug ring busted, bogus abatacept among products</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>Recently, the Wuhan City Public Security Bureau uncovered a counterfei......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Tue, 27 Jul 2010 09:24:23  +0800</pubDate></item><item><title>MOH announcement re-emphasizes rural health improvements and coverage</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The Ministry of Health (MOH) recently issued regulations to improve ru......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Mon, 26 Jul 2010 18:01:43  +0800</pubDate></item><item><title>Renminbi-ology: Biotech Billionaire list published</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>MoneyWeek recently published its third "China's Top 3,000 Richest Fami......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Mon, 26 Jul 2010 16:45:33  +0800</pubDate></item><item><title>New retail pharmacy to focus on premium branded drugs</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>A new retail drug chain focusing exclusively on higher-quality/branded......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Mon, 26 Jul 2010 14:21:28  +0800</pubDate></item><item><title>SFDA calls attention to lamivudine and telbivudine ADRs</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>State Food and Drug Administration (SFDA) officials recently cautioned......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Mon, 26 Jul 2010 12:59:42  +0800</pubDate></item></channel></rss>